| Literature DB >> 34308239 |
Astère Manirakiza1, Laurent Irakoze2, Sebastien Manirakiza3.
Abstract
Many years ago, Aloe Vera was cited to have a lot of therapeutic properties including; anti-microbial, anti-viral, anti-cancer, anti-oxidant, anti-inflammatory, skin protection, wound healing, and regulation of blood glucose and cholesterol. However, Aloe could present some side effects. This review focused on the latest discoveries regarding the therapeutic role of Aloe plant or its compounds on the acquired biological capabilities for tumour growth and progression namely; evading growth suppressor, avoiding immune destruction, enabling replicative immortality, tumour promoting inflammation, activating invasion and metastasis, inducing angiogenesis, genome instability and mutation, resisting cell death, deregulating cellular energetics and sustaining proliferating signalling. It clarified the anti-cancer activities it exerts on different types of cancer and also highlighted some pro-oncogenic pathways that can be disrupted by different compounds of Aloe. © The East African Health Research Commission 2021.Entities:
Year: 2021 PMID: 34308239 PMCID: PMC8291210 DOI: 10.24248/eahrj.v5i1.645
Source DB: PubMed Journal: East Afr Health Res J ISSN: 2520-5277
The Compounds of Aloe and Mode of Action on Cancers
| Compounds | Country | Experiments | Effects | Type of cancer | Mode of action | References |
|---|---|---|---|---|---|---|
| Aloe Vera | Italy | Vivo | Anticancer | Pleural tumour from hepatoma | Not described | |
| Aloe Vera | Egypt | Vitro | Anticancer & apoptosis | hepatocellular carcinoma | Increase P53 and decrease Bcl-2 genes expressions | |
| Aloe Vera | Poland | Vivo | Anti-angiogenesis, photocytotoxicity | Sarcoma | Not described | |
| Aloe Vera | Japan | Vitro | Suppression cell proliferation | Neuroblastoma | Probably by suppressing CCND2 transcript levels | |
| Aloe Vera | UAE | Vitro | Inhibition of cancer cell growth | Breast and cervical cancer | Apoptotic pathway | |
| Aloe Vera | USA | Vivo | Inhibition of tumour | Ocular Surface Squamous Neoplasia | Not described | |
| Aloe Vera extract | Korean | Vitro | Induction of apoptosis | Hepatocellular carcinoma | ATP depletion-related impairment of mitochondria, which is caspase-independent | |
| Aloe arb-orescens Miller | Japan | Vivo | Anticancer & ant-proliferative | Duodenal tumour | Not described | |
| Aloe arborescens | Italy | Vitro/Vivo | Tumour grow th inhibition | Glioblastoma | Not described | |
| Aloe-Emodin | Taiwan | Vitro | Antiproliferarative | Colon carcinoma | Inhibition of casein kinase II activity, The release of apoptosis-inducing factor and cytochrome c, Caspase-3 activation | |
| Aloe-emodin | China | Vitro | Antiproliferative, increase apoptosis | Oral squamous carcinoma | Activation of caspase-9 and caspase-3 proteins | |
| Aloe-emodin | Taiwan | Vitro | Induction of-apoptosis | Gastric carcinoma | Release the apoptosis-inducing factor and cytochrome c from mitochondria, Activation of caspase-3 | |
| Aloe-Emodin | China | Vitro | Suppression of cell viability induction of apoptosis, endoplasmic reticulum stress | Colorectal | Activation of factor C/EBP homologous protein and caspase-12 | |
| Aloe-Emodin | Poland | Vitro | Induction of apoptosis | Cervical Cancer | Mitotic catastrophe, inhibition of cell division in the G2/M phase, reduction of viability | |
| Aloe-emodin (Nano) | China | Vitro/Vivo | Antiprolifercell carcinoma ative induction of cell cycle arrest & apoptosis, antitumour growth | Lung squamous | Cleavage of Caspase-3, poly (ADP-ribose), polymerase (PARP), Caspase-8 and Caspase-9, Enhanced reactive oxygen species (ROS) production | |
| Aloe-emodin | Italy | Vitro/Vivo | Tumour growth inhibition | Glioblastoma | Reduction pAKT phosphorylation, block of cell cycle in S and G2/M phase | |
| Aloe-emodin | Malaysia | Vitro | Induction of apoptosis and cell cycle arrest in S phase | Malignant glioma | Promotion of the loss of mitochondrial membrane potential | |
| Aloe-emodin | China | Vitro | Induction of cell death through S-phase arrest and apoptosis | Tongue squamous carcinoma | Promotion of p53, p21 and p27, Promotion of the release of apoptosis-inducing factor, endonuclease G, pro-caspase-9 and cytochrome c | |
| Aloe-emodin | Korea | Vitro/Vivo | Suppression of cancer progression | Prostate cancer | Binding with mTORC2 and inhibit its kinase activity | |
| Aloe-emodin | India | Vitro | Induction of cell cycle arrest in G2/M phase & apoptosis | Colon cancer | Activation of Caspase-6 | |
| Aloe-emodin | Taiwan | Vitro | Induction of cell cycle arrest in G2/M phase & apoptosis | Nasopharyngeal carcinoma | Caspase-8-mediated activation of the mitochondrial death pathway | |
| Aloe-emodin | China | Vitro | Induction of cell cycle arrest in G2/M phase & apoptosis | Bladder Cancer | Activation of p53, p21, Fas/APO-1, Bax and caspase-3. | |
| Aloe-emodin | China | Vitro | Induction of-growth inhibitory through cell cycle arrest in G2/M phase | Cervical cancer | Cell cycle arrest in G2/M phase | |
| Aloe-emodin | Taiwan | Vitro | Induction of cell cycle arrest in G1 phase and apoptosis | Hepatoma | Induction of p53 and p21 expression | |
| Aloe-emodin | USA | Vitro | Inhibits proliferation, and induces apoptosis | Glioma | Delaying S phase progression, reduction of poly (ADP-ribose) polymerase and protein kinase C, cleavage of caspase 7 | |
| Aloe-emodin | Taiwan | Vitro | Induction of apoptosis | Lung squamous cell carcinoma | Activation of caspase-3, caspase-8, and caspase-9 | |
| Aloe-emodin | Italy | Vitro/Vivo | Induction of apoptosis | Neuroectodermal Tumours | Not well described | |
| Aloe-emodin | Israel | Vivo | Inhibition of cells proliferation | Merkel cell carcinoma | Not described | |
| Aloe-emodin | Italy | Vitro | Cells antiproliferative and differentiation | Leukaemia | Not described | |
| Aloe-emodin | Taiwan | Vitro | Induction of cell cycle arrest in G2/M phase & antiproliferative | Promyelocytic leukaemia | Not described | |
| Aloe-emodin | Italy | Vitro | Anticancer | Multidrug resistant leukaemia cells | Not described | |
| Aloe-emodin | Spain | Vivo | Anti-angiogen-esis | Not specific | Inhibits endothelial cell proliferation | |
| Aloe-emodin | India | Vitro | Inhibition of cell migration/angiogenesis | Colon cancer | Down-regulating of Matrix Metalloproteinase (MMP-2/9), RhoB and VEGF by reducing DNA binding activity of NF-kB | |
| Aloe-emodin | China | Vitro | Suppression of the metastasis | Breast cancer | Inhibition of the capabilities of invasion and migration of cells probably | |
| Aloe-emodin | Italy | Vitro | Anticancer and anti-proliferation | Melanoma | Decreasing the secretion of matrix mettalloprote-inase-9 | |
| Aloe-emodin | China | Vitro | Arrest the cell cycle in G2/M phase | Gastric cancer | Inhibition of the expressions of protein kinase C and c-myc | |
| Aloe-emodin | Taiwan | Vitro | Induction of cells death | Lung non-small cell carcinoma | Decreasing Cyclic adenosine monophosphate (cAMP)-dependent protein kinase, protein kinase C, Bcl-2, caspase-3 and p38 | |
| Aloe-emodin | Taiwan | Vitro | Induction of DNA damage and apoptosis | Lung carcinoma | Production of generation of reactive oxygen species and decrease in the mRNA of DNA repair enzymes | |
| Aloe-emodin | China | Vitro/Vivo | Antineoplastic (cell proliferation was blocked in G1 phase) | Oral mucosa carcinoma | Reactive oxygen species (ROS) generated and up-regulation of Caspase-3 | |
| Aloe-emodin | China | Vitro | Inhibition of tumour | Gastric cancer | Not described | |
| Aloe-emodin | Serbia & Montenegro | Vivo | Anticancer, induction of apoptosis | Glioma | Inhibition of extra cellular signal-regulated kinases 1 and 2 (ERK1/2) independent induction | |
| Aloe-emodin | Singapore | Vitro | Induction of apoptosis and cell cycle arrest in G2/M | Hepatocellular carcinoma | Induction of higher caspase-3-like activity | |
| Aloe-emodin | China | Vitro | Anticancer | Tongue Cancer | Induction of DNA damage and inhibition of DNA repair gene expression | |
| Aloe-emodin | Taiwan | Vitro | Suppression of breast cancer cell proliferation | Breast Cancer | Targeting estrogen receptor protein stability through distinct mechanisms | |
| Emodin | Taiwan | Vivo | Cytotoxicity | Lung squamous cell carcinoma | Activation of caspase-3, caspase-9 and caspase-8, induction of cell death by Bax death pathway and Fas pathway | |
| Emodin | China | Vitro | Induction of apoptosis | Hepatocellular carcinoma | Mitochondrial apoptosis pathway through cell cycle arrest and ROS generation | |
| Emodin | China | Vitro | Induction of cells death | Osteosarcomama | Initiation of ROS-dependent mito-chondria-induced and ROS-independent endoplasmic reticulum stress-induced apoptosis | |
| Emodin | China | Vitro | Induction of apoptosis | Lung cancer | Endoplasmic reticulum stress and the TRIB 3/NF-KB pathway | |
| Emodin | China | Vitro/Vivo | Induction of apoptosis | Hepatocellular carcinoma | Mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/AKT signalling pathways | |
| Emodin | China | Vitro/Vivo | Anticancer and antiproliferative | Pancreatic cancer Liver metastasis of pancreatic cancer | Inhibition of epithelial mesenchymal transition by raising increasing the content of miR-1271 | |
| Emodin | China | Vitro | Promotion of the arrest of cell proliferation | Lymphoma | Increase in the UHRF1D-NMT3 A-TAp73/ANp73 pathways. | |
| Emodin | China | Vitro | Induction of apoptosis | Colon cancer | Induction of autophagy, during which ROS generation is of the essence. | |
| Emodin | China | Vitro | Induction of growth inhibitionand apoptosis | Breast cancer | Reduction of the level of Bcl-2 and increased levels of cleaved caspase-3, PARP, p53 and Bax | |
| Emodin | China | Vitro | Induction of cells growth inhibition and apoptosis | Acute myeloid leukaemia | Inhibition of the PI3K/Akt signalling pathway by activation of caspase cascades | |
| Emodin | China | Vitro | Induction of apoptosis | Colon cancer | ROS is a trigger of emodin inducing apoptosis and p53 expression increases under oxidative stress, leading to Bax-mediated mitochondrial apoptosis | |
| Emodin | China | Vitro | Triggers apoptosis | Neuroblastoma | Mechanism involving both reactive oxygen species and nitric oxide | |
| Emodin | China | Vitro | Induction of apoptosis | Cervical cancer | Intrinsic mitochondrial and extrinsic death receptor pathways | |
| Emodin | India | Vitro | Induction of apoptosis | Hepatocellular carcinoma | Blocking activation of STAT3 (Signal transducer and activator of transcription 3) | |
| Emodin | China | Vitro | Induction of cells growth inhibition and apoptosis | Breast carcinoma | Modulation of the expression of apoptosis-related genes | |
| Emodin | China | Vitro | Induction of apoptosis | Liver cancer | A multifaceted complex cascade of events | |
| Emodin | China | Vitro/Vivo | Induction of apoptosis and inhibition of cells proliferation | Pancreatic cancer | Declining the mitochondrial membrane potential | |
| Emodin | China | Vitro | Inhibition of cells proliferation and induction of apoptosis | Prostate cancer | Androgen receptor and and p53-p21 pathways and the mitochondrial pathway. | |
| Emodin | China | Vitro | Inhibition of cell growth and induction of apoptosis | Leukaemia | Inhibition of phosphorylation of P210 protein, down-regulation of P210 protein expression and activation of caspase-3 | |
| Emodin | China | Vitro | Induction of cells growth inhibition and apoptosis | Leukaemia | Inhibition of Akt [Protein kinase B (PKB)] signal pathway | |
| Emodin | Japan | Vitro | Induction of apoptosis | Multiple myeloma | Inhibition of interleukin-6-induced JAK2/STAT3 pathway | |
| Emodin | Taiwan | Vitro | Induction of apoptosis | Lung adenocarcinoma | Reactive oxygen species-dependent mitochondrial signaling pathway | |
| Emodin | Taiwan | Vitro | Induction of apoptosis | Promyeloleukemia | Activation of caspase 3 cascade but independent of reactive oxygen species production | |
| Emodin | Indian | Vitro | Induction of apoptosis | Cervical cancer | Caspase-dependent and presumably through the mitochondrial pathway, by the activation of caspases-3, -9 and cleavage of poly (ADP-ribose) polymerase | |
| Emodin | Japan | Vitro | Induction of apoptosis | Hepatocellular carcinoma | Enhancement of generation of ROS, DeltaPsim disruption and caspase activation | |
| Emodin azide Methyl anthraq-uin-one derivative | China | Vitro | Inhibition of cell growth and induction of apoptosis | Breast cancer and lung adenocarcinoma with over expression of HER2/neu | Disruption of the PI3K/Akt-dependent pathway | |
| Aloin | Serbia | Vitro | Antiproliferative, Cell cycle arrest in the S phase, Apoptosis | Cervical uterine carcinoma | Changes in the activity of almost all anti-oxidant enzyme | |
| Aloin | China | Vitro Vivo | Inhibit of tumour angio-genesis growth | Colorectal cancer | Suppression of activation of VEGF receptor (VEGFR) 2 and STAT3 phosphorylation in endothelial cells | |
| Aloin (Barbaloin) | China | Vitro/Vivo | Reduction of gastric cancer cell viability & induction of apoptosis | Gastric cancer | Induction of autophagy and ROS generation | |
| Aloin | Italy | Vitro | Antineoplastic & antimetastatic | Melanoma | Induction of melanoma cell differentiation | |
| Acemannan | USA | Vivo | Anticancer | Fibrosarcoma | Macrophage activation and release of tumour necrosis factor, interl-, eukin-1 and interferon | |
| Acemannan | USA | Vivo | Infiltration of tumour by immune system cells, became necrotic & regressed | Sarcoma | Stimulation of synthesis of monokines resulted in the initiation of immune attack, necrosis, and regression of tumour | |
| Aloemannan | Japan | Vivo | Inhibition of tumour | Sarcoma | Not described | |
| Dichlo-romethane | Japan | Vitro | Cells growth inhibition | Ehrlich ascites tumour | Decrease of cells in the S and G2/M phase of the cell cycle; inhibition of DNA synthesis | |
| Aloesin | China | Vitro/Vivo | Induction of apoptosis, inhibition of tumour growth, migration and invasion | Ovarian cancer | Inhibition of the mitogen activated protein kinase (MAPK) signaling pathway | |
| Di (2-ethylh-exyl) phthalate (DEHP) | Korea | Vitro | Growth inhibition | Leukaemia | Not described | |
| Diethy-lhexyl-phthalate | Korea | Vitro | Induction of apoptosis | Leukaemia | Not described | |